Fund Holdings — BVF INC/IL

Total Portfolio Value:
$3.04B
Total Bought:
$184.97M
Total Sold:
$859.96M
Net Transaction:
-$674.98M
Securities
▲▼
SharesValue
Q2 2026
▲▼
Q3 2026
▲▼
Change
▲▼
Q2 2026
▲▼
Q3 2026
▲▼
Weight (%)
▲▼
Change
▲▼
Revolution Medicines, Inc.(RVMD)2,965,1602,460,560-504,600$555.32M$505.05M16.61%-$50.26M
Kymera Therapeutics, Inc.(KYMR)3,872,0523,872,0520$444.01M$432.86M14.24%-$11.15M
GH Research PLC(GHRS)8,650,1588,650,1580$232.52M$203.11M6.68%-$29.41M
MoonLake ImmunotherapeuticsCL A(MLTX)16,001,28416,001,2840$311.54M$187.22M6.16%-$124.33M
Xencor, Inc.(XNCR)7,133,7206,227,034-906,686$114.85M$155.36M5.11%+$40.51M
Nektar Therapeutics(NKTR)2,391,0752,134,007-257,068$166.92M$129.20M4.25%-$37.72M
Alkermes plcSHS(ALKS)2,154,7042,847,100+692,396$112.90M$115.36M3.79%+$2.47M
Stoke Therapeutics, Inc.(STOK)2,547,5573,608,968+1,061,411$83.36M$93.83M3.09%+$10.48M
Tyra Biosciences, Inc.(TYRA)1,476,1964,215,886+2,739,690$47.15M$92.20M3.03%+$45.05M
Zymeworks Inc.(ZYME)3,649,1423,464,142-185,000$95.39M$91.77M3.02%-$3.62M
Cullinan Therapeutics Inc5,750,6835,750,6830$104.72M$88.27M2.90%-$16.45M
Structure Therapeutics IncADS3,366,8232,691,426-675,397$180.70M$84.16M2.77%-$96.54M
Palvella Therapeutics, Inc.(PVLA)672,789607,149-65,640$102.82M$83.74M2.75%-$19.07M
Kura Oncology Inc8,445,7696,690,108-1,755,661$92.65M$71.65M2.36%-$21.00M
Ac Immune SaSHS19,822,43619,822,4360$47.18M$51.93M1.71%+$4.76M
Monte Rosa Therapeutics Inc4,460,8864,276,578-184,308$107.95M$51.02M1.68%-$56.93M
Entera Bio LtdSHS2,425,00017,052,893+14,627,893$4.29M$49.62M1.63%+$45.33M
Olema Pharmaceuticals Inc5,295,8935,295,8930$66.25M$45.76M1.51%-$20.50M
Crescent Biopharma Inc.2,748,7633,093,590+344,827$49.48M$45.14M1.48%-$4.34M
4d Molecular Therapeutics In2,879,2892,879,2890$38.29M$41.20M1.36%+$2.91M
Immunocore Holdings plcADS(IMCR)1,294,4631,230,909-63,554$41.10M$37.28M1.23%-$3.81M
Annexon Inc8,698,1738,278,164-420,009$49.67M$35.02M1.15%-$14.65M
Mirum Pharmaceuticals, Inc.(MIRM)1,056,027407,226-648,801$123.63M$34.81M1.15%-$88.82M
Sagimet Biosciences IncCOM SER A2,500,0003,500,000+1,000,000$19.32M$34.58M1.14%+$15.26M
Pyxis Oncology Inc011,826,140+11,826,140$0$27.55M0.91%+$27.55M
Absci Corporation2,361,6742,361,6740$27.37M$25.44M0.84%-$1.94M
Invivyd Inc28,165,00028,165,0000$24.57M$24.51M0.81%-$64.8K
Anteris Technologies Global3,000,0003,000,0000$29.55M$23.31M0.77%-$6.24M
Foghorn Therapeutics Inc5,842,0005,842,0000$28.51M$20.86M0.69%-$7.65M
Sutro Biopharma Inc1,251,7881,251,7880$41.56M$20.17M0.66%-$21.39M
Q32 Bio Inc2,350,0002,350,0000$29.94M$19.43M0.64%-$10.50M
Alector Inc010,046,206+10,046,206$0$18.59M0.61%+$18.59M
Eledon Pharmaceuticals Inc6,293,2826,293,2820$24.80M$15.92M0.52%-$8.87M
Disc Medicine, Inc.(IRON)1,153,612233,300-920,312$84.38M$15.27M0.50%-$69.10M
Avalo Therapeutics Inc2,075,545907,406-1,168,139$38.36M$13.91M0.46%-$24.45M
Onkure Therapeutics IncCL A3,235,7784,045,278+809,500$14.76M$11.02M0.36%-$3.73M
Immunic Inc765,295765,2950$11.76M$7.12M0.23%-$4.65M
Tcgx Acquisition CorpCL A0500,000+500,000$0$6.25M0.21%+$6.25M
Research Alliance Corp IvCL A0500,000+500,000$0$5.92M0.19%+$5.92M
Research Alliance Corp IiiCL A500,000500,0000$5.35M$5.36M0.18%+$5.0K
Molecular Partners AgADS1,353,9681,353,9680$5.15M$5.19M0.17%+$40.6K
Imagenebio Inc1,110,0021,110,0020$6.55M$5.08M0.17%-$1.47M
X4 Pharmaceuticals Inc2,233,7421,576,624-657,118$10.43M$4.57M0.15%-$5.86M
Inventiva SaADS686,040686,0400$2.59M$2.53M0.08%-$61.7K
Tscan Therapeutics Inc5,564,2905,564,2900$5.45M$1.75M0.06%-$3.70M
Engene Therapeutics IncW EXP 10 31 202945,402945,4020$274.1K$189.2K0.01%-$84.9K
Tenax Therapeutics Inc339,54925,000-314,549$4.94M$47.3K0.00%-$4.89M
Xoma Royalty Corporation7,593,3030-7,593,303$322.72M$0—-$322.72M
Page 1 of 1
BVF INC/IL — 13F Holdings — Q3 2026 | TickerTrail